Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in IMUX — Immunic, Inc.

CIK 1595888 NEW YORK, NY
Back to IMUX Full portfolio

Position in IMUX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,378,488
+$646,829 QoQ
Shares Held
89,687
+36.1% QoQ
Ownership
0.657%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 55 holders
Holding Since
Dec 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMUX Over Time

Shares Held

Position Value (USD)

Derivatives in IMUX

reported options exposure · as of Jun 30, 2026
CallValue
$235,161
CallShares
15,300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,861,470 across 292 Biotechnology names. IMUX ranks #73 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in IMUX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,378,488 89,687
2026-06-30 $235,161 15,300
2026-03-31 $16,761 15,100
2026-03-31 $731,659 659,153
2026-03-31 $147,075 132,500
2025-12-31 $153,084 286,677
2025-09-30 $172,281 195,331
2025-03-31 $226,066 207,401
2024-12-31 $54,675 54,675
2024-09-30 $115,993 70,299
2024-06-30 $35,238 31,746
2024-03-31 $77,249 58,523
2023-06-30 $33,024 13,157
2022-12-31 $100,104 71,503
2022-06-30 $240,627 69,345
2022-03-31 $156,075 13,812
2021-12-31 $281,424 29,407
2020-12-31 $488,775 31,967